You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Molecular Biomarkers of Dangerous Intracranial Aneurysms
SBC: NEUROVASCULAR DIAGNOSTICS, INC. Topic: 103Abstract Rupture of intracranial aneurysmsIAscauses intracranial hemorrhaging that leads to high rates of neurological deficits and deathAlthough rupture rates are lowclinicians must decide whether to treat or monitor these potentially dangerous lesionsIn the current clinical practicethe most common metric to measure risk of rupture is aneurysm sizemm ormmHoweverclinical data show that small aneur ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A deep learning platform to evaluate the reliability of scientific claims by citation analysis.
SBC: Scite, Inc. Topic: NIDAThe opioid epidemic in the United States has been traced to aletter reporting in the prestigious New England Journal of Medicine that synthetic opioids are not addictiveA belated citation analysis led the journal to append this letter with a warning this letter has beenheavily and uncritically citedas evidence that addiction is rare with opioid therapyThis epidemic is but one example of how unreli ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of Serious Games and Physical Activities Instructed by a Social Robot for Improving the Well-being of Elderly Individuals with Alzheimer's Disease and Dementia
SBC: Dream Face Technologies, LLC Topic: NIAThe objective of the proposed direct Phase-II SBIR project is to develop and study and the effectiveness of Serious Games and physical Activities played/performed by elderly people with Alzheimer’s disease and AD- related Dementias in interaction with Ryan, our successfully piloted Socially Assistive Robot (SAR). Ryan is an intelligent conversational life-like social robot, designed to improve t ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Transcutaneous auricular neurostimulation for neonatal abstinence syndrome
SBC: SPARK BIOMEDICAL INC. Topic: R43Neonatal abstinence syndromeNASis a condition in which infants undergo withdrawal after exposure to prescription or non prescription opioids such as methadone or heroin in uteroNAS babies exhibit hyperirritability of the central nervous system and respiratorygastrointestinaland autonomic symptomsThese symptoms usually appear withintohours after birthAs ofan infant with NAS was born everyminutes in ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Novel Strategies for Development of a Multiplexed Test with Expanded Content for Spinal Muscular Atrophy
SBC: ASURAGEN, INC. Topic: 102SummaryThe overall goal of this project is to develop a cost effective multiplexed diagnostic test for spinal muscular atrophySMAto rapidly and accurately analyze multiple classes of disease causingdisease modifying DNA variantsand carrier status markersUltimatelythe proposed test will have a far reaching impact by expanding the identification and stratification of patients who may benefit from ne ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Evaluating the Usability, Efficacy and Commercial Utility of a Digital Platform to Deliver Comprehensive Treatment for Opioid Use Disorder
SBC: Boulder Care, Inc. Topic: NIDAPROJECT SUMMARY Opioid use disorderOUDis a problem of national concernMedication based treatmentMTreduces opioid useassociated risk behaviors and deathDespite evidence supporting MT with buprenorphinein more thanof US countiesmainly ruralthere are no prescribersPatients travel long distancesjoin waitlistsor go without MTOther barriers to care include lack of transportationcompeting demandsworkchil ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
BD2K product for enhancing phenotypic screens
SBC: GENECENTRIX INC. Topic: NIDAThe public health problem addressed by the proposed project is the critical, long-term absence of progress in anti-addiction medication discovery and development. GeneCentrix’ “historeceptomics” technology has the potential to alter this trend by providing advanced insights during the process of anti-addiction medication discovery and development. Digital/computational advanced insights are ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
GMP Production of a Tau Oligomer Inhibitor to Enable Clinical Development for ADRD
SBC: OLIGOMERIX INC Topic: NIATITLE: GMP Synthesis of a Tau Oligomer Inhibitor to Enable Clinical Development for ADRD PROJECT SUMMARY - SBIR Funding Opportunity: NIA PAS-18-187, andquot;Advancing Research on Alzheimerandapos;s Disease (AD) andamp; AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)andquot; The long-term goal of this program is to develop a disease-modifying, small molecule drug for Alzheimer’s dis ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of a rapid diagnostic assay for Myasthenia Gravis
SBC: ATTOGENE CORPORATION Topic: 101Project Summary AbstractThe physiological effect of autoantibody binding to the motor endplate junction nicotinic acetylcholine receptorsAchRcauses numerous symptoms associated with Myasthenia GravisMGand is characterized by drooping of one or both eyesblurred or double visionchange in facial expressiondifficulty swallowingshortness of breathimpaired speech and weakness of muscle functionIn some c ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
MicroRNA-based Diagnostic Biomarker for Pulmonary Hypertension
SBC: MIRNA ANALYTICS LLC Topic: NHLBIAbstract Mirna Analytics is proposing to develop a microRNAmiRNAmarker for pulmonary hypertensionThis proposal is focused on the identification of optimal miRNAandapos s to form composite markers that can be measured in the serum plasmaPulmonary hypertensionan excessive increase of the pressure in the pulmonary circulationcan be due to many different reasonsPulmonary hypertension can be a deadly d ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health